Home › Forums › Main Forum › Patient Stories › SVR › Impact of Sustained Virological Response in Hepatitis C Therapy
Mgalbrai found this 4 page article as part of one of his regular HCV Newdrugsblogspot posts but I felt that this link held enough valuable information to justify repeating it in this section of the forum. Thanks Mike.
http://www.healio.com/hepatology/hepatitis-c/news/print/hcv-next/%7B53f611f2-31c8-4abc-bd7a-b094c696caef%7D/impact-of-sustained-virologic-response-in-hepatitis-c-therapy
G3a since ’78 – Dx ’12 – F4 (2xHCC) 24wk Tx – PEG/Riba/Dac 2013 relapsed 24wk Tx – Generic Sof/Dac/Riba 2015/16 relapsed 16wk Tx – 12/01/17 -> 03/05/17 NS3/NS5a + Generic Sof SVR7 – 22/06/17 UND SRV12 – 27/07/17 UND SVR24 – 26/10/17 UND
This graph is particularly reassuring:
YMMV